Latest filing published 10 Dec 2010 for Navidea Biopharmaceuticals, INC., €39k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Owen E. Johnson: trading record in brief
All filings by Owen E. Johnson on record concern Navidea Biopharmaceuticals, Inc. Over a trading history stretching from 20 August 2008 to 8 December 2010, the count stands at 6 filings.
The open-market record is one-sided, with 6 purchases worth €76k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2010 to date brings 2 purchases and no sales.
The median purchase comes to €11k.
The latest filing, published on 10 December 2010, reports an open-market purchase of €39k in Navidea Biopharmaceuticals, Inc. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Owen E. Johnson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 25,000 shares@ US$2.05Common StockSEC:0001225208-10-026702:0Canonical exit: 8 Mar 2011 (T+90)
- 10,000 shares@ US$1.90Common StockSEC:0001225208-10-008783:0Canonical exit: 17 Jun 2010 (T+90)
- 13,500 shares@ US$1.35Common StockSEC:0001225208-09-017356:0Canonical exit: 12 Nov 2009 (T+90)
- 1,000 shares@ US$1.34Common StockSEC:0001225208-09-017356:1Canonical exit: 12 Nov 2009 (T+90)
- 500 shares@ US$1.31Common StockSEC:0001225208-09-017356:2Canonical exit: 12 Nov 2009 (T+90)
- 20,000 shares@ US$0.66Common StockSEC:0001225208-08-013978:0Canonical exit: 18 Nov 2008 (T+90)
6 of 6 declarations